These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6358031)

  • 1. Entry of Shigella dysenteriae toxin into HeLa cells.
    Eiklid K; Olsnes S
    Infect Immun; 1983 Nov; 42(2):771-7. PubMed ID: 6358031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionic requirements for entry of Shiga toxin from Shigella dysenteriae 1 into cells.
    Sandvig K; Brown JE
    Infect Immun; 1987 Feb; 55(2):298-303. PubMed ID: 3542829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
    Sandvig K; Olsnes S; Brown JE; Petersen OW; van Deurs B
    J Cell Biol; 1989 Apr; 108(4):1331-43. PubMed ID: 2564398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.
    Jacewicz M; Feldman HA; Donohue-Rolfe A; Balasubramanian KA; Keusch GT
    J Infect Dis; 1989 May; 159(5):881-9. PubMed ID: 2651533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.
    Neill RJ; Gemski P; Formal SB; Newland JW
    J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin.
    Brown JE; Rothman SW; Doctor BP
    Infect Immun; 1980 Jul; 29(1):98-107. PubMed ID: 6156915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells.
    Hale TL; Formal SB
    Am J Clin Nutr; 1980 Nov; 33(11 Suppl):2485-90. PubMed ID: 7001884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
    Obrig TG; Del Vecchio PJ; Brown JE; Moran TP; Rowland BM; Judge TK; Rothman SW
    Infect Immun; 1988 Sep; 56(9):2373-8. PubMed ID: 3044997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin.
    Jacewicz M; Keusch GT
    J Infect Dis; 1983 Nov; 148(5):844-54. PubMed ID: 6355319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.
    Griffin DE; Gemski P
    Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Mol Microbiol; 1989 Sep; 3(9):1231-6. PubMed ID: 2677606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
    Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding.
    Brown JE; Obrig TG; Ussery MA; Moran TP
    Microb Pathog; 1986 Aug; 1(4):325-34. PubMed ID: 3334156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
    J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.
    Lindberg AA; Brown JE; Strömberg N; Westling-Ryd M; Schultz JE; Karlsson KA
    J Biol Chem; 1987 Feb; 262(4):1779-85. PubMed ID: 3543013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of stx, a determinant essential for high-level production of shiga toxin by Shigella dysenteriae serotype 1, near pyrF and generation of stx transposon mutants.
    Sekizaki T; Harayama S; Brazil GM; Timmis KN
    Infect Immun; 1987 Sep; 55(9):2208-14. PubMed ID: 3040592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.